Outcome | Groups | P-value b,c | |
---|---|---|---|
CCR (n = 44) | ICR (n = 44) | ||
TG (mg/dL) | |||
 Baseline | 165.0 (126) | 180.5 (115) |  |
 8-week | 162 (85) d* | 133 (92) ** | 0.44 |
 Change e | 16.0 (113) | 23.5 (103) | 0.49 |
Cholesterol (mg/dL) | |||
 Baseline | 190.1 ± 38.1 | 178.6 ± 30.3 |  |
 8-week | 175.7 ± 37.4 * | 174.1 ± 30.9 | 0.57 |
 Change | 14.4 ± 37.1 | 4.56 ± 33.8 | 0.19 |
LDL-C (mg/dL) | |||
 Baseline | 107.7 ± 29.0 | 98.4 ± 28.5 |  |
 8-week | 102.9 ± 29.4 | 103.4 ± 26.1 | 0.31 |
 Change | 4.8 ± 26.2 | −5.1 ± 29.1 | 0.09 |
HDL-C (mg/dL) | |||
 Baseline | 42.1 ± 10.6 | 39.1 ± 7.7 |  |
 8-week | 39.7 ± 9.3* | 39.4 ± 6.7 | 0.28 |
 Change | 2.4 ± 7.0 | −0.3 ± 7.2 | 0.08 |
Total: HDL-C | |||
 Baseline | 4.7 ± 1.2 | 4.9 ± 1.4 |  |
 8-week | 4.6 ± 1.1 | 4.5 ± 1.0 | 0.73 |
 Change | 0.1 ± 1.0 | 0.3 ± 1.5 | 0.67 |
TG:HDL-C | |||
 Baseline | 5.2 ± 3.0 | 5.9 ± 4.4 |  |
 8-week | 4.5 ± 2.4 | 4.2 ± 2.2 * | 0.31 |
 Change | 0.7 ± 3.1 | 1.7 ± 4.3 | 0.42 |
non-HDL -C | |||
 Baseline | 148.0 ± 36.7 | 139.5 ± 31.4 |  |
 8-week | 135.9 ± 34.7 * | 134.7 ± 30.6 | 0.69 |
 Change | 12.0 ± 35.4 | 4.8 ± 34.3 | 0.33 |
FBS (mg/dL) | |||
 Baseline | 89.5 (16) | 88.0 (26) |  |
 8-week | 91.0 (24) | 88.0 (15) | 0.26 |
 Change | −1.0 (18) | 0.0 (21) | 0.04 |
Insulin (μIU/mL) | |||
 Baseline | 22.0 ± 9.7 | 18.2 ± 8.1 |  |
 8-week | 21.3 ± 11.2 | 16.01 ± 5.5 * | 0.17 |
 Change | 0.8 ± 6.5 | 2.1 ± 6.9 | 0.34 |
HOMA-IR | |||
 Baseline | 3.7 (3) | 3.5 (3) |  |
 8-week | 4.3 (3) | 3.5 (2) * | 0.03 |
 Change | 0.0 (1) | 0.3 (1) | 0.03 |
Adiponectin (μg/mL) | |||
 Baseline | 8.6 ± 3.0 | 8.1 ± 3.0 |  |
 8-week | 8.6 ± 2.9 | 7.9 ± 3.0 | 0.30 |
 Change | −0.1 ± 2.3 | 0.3 ± 2.4 | 0.50 |
ALT (IU/L) | |||
 Baseline | 28.2 ± 19.4 | 20.5 ± 10.9 |  |
 8-week | 26.7 ± 16.4 | 19.3 ± 8.2 | 0.12 |
 Change | 1.4 ± 20.6 | 1.1 ± 11.1 | 0.82 |
AST (IU/L) | |||
 Baseline | 23.3 ± 11.0 | 19.0 ± 5.5 |  |
 8-week | 23.0 ± 9.7 | 19.0 ± 5.1 | 0.15 |
 Change | 0.3 ± 11.8 | 0.0 ± 5.8 | 0.96 |